Difference between revisions of "Basic Behavioral Neurology Clinical Concepts"
Line 2: | Line 2: | ||
- Alzheimer Disease Research Center (ADRC) criteria (Albert et al, 2011) | - Alzheimer Disease Research Center (ADRC) criteria (Albert et al, 2011) | ||
− | + | # Concern regarding an intraindividual change in cognition | |
− | + | # Impairment in one or more cognitive domains | |
− | + | # Preservation of independence in functional abilities | |
− | + | # Not demented | |
− | |||
− | |||
− | |||
− | |||
- Petersen criteria (Petersen 2016) | - Petersen criteria (Petersen 2016) | ||
− | + | # Memory complaints per subject and/or collateral source | |
− | + | # Intact activities of daily living | |
− | + | # Clinical dementia rating scale of 0.5 | |
− | + | # Performance on a delayed memory test that is at least one standard deviation below the mean for the subject’s age | |
− | |||
− | |||
− | |||
− | |||
- Epidemiology (Petersen 2016) | - Epidemiology (Petersen 2016) | ||
− | + | # 15-20% of patients over the age of 60 have MCI | |
− | + | # The annual rate in which MCI progresses to dementia varies between 8% and 15% per year | |
− | |||
− | |||
'''Levels of Functioning''' (Salardini 2019) | '''Levels of Functioning''' (Salardini 2019) | ||
− | + | * Activities of daily living: dressing, bathing, toileting, continence, transferring, eating | |
− | + | * Instrumental activities of daily living: shopping, preparing food, housework, laundry, use transportation, medication compliance, handling finances | |
− | + | * Advanced activities of daily living: vocational skills, vocational knowledge, hobby-related mastery, music, art | |
− | |||
− | |||
− | |||
Line 42: | Line 29: | ||
Cognitive or behavioral (neuropsychiatric) symptoms that: | Cognitive or behavioral (neuropsychiatric) symptoms that: | ||
− | + | # Interfere with the ability to function at work or at usual activities; and | |
− | + | # Represent a decline from previous levels of functioning and performing; and | |
− | + | # Are not explained by delirium or major psychiatric disorder. | |
− | + | # Cognitive impairment is detected and diagnosed through a combination of | |
− | + | ## History-taking from the patient and a knowledgeable informant and | |
− | + | ## Objective cognitive assessment, either a “bedside” mental status examination or neuropsychological testing | |
− | + | # The cognitive or behavioral impairment involves a minimum of two of the following domains: | |
− | + | ## Impaired ability to acquire and remember new information | |
− | + | ## Impaired reasoning and handling of complex tasks, poor judgment | |
− | + | ## Impaired visuospatial abilities | |
− | + | ## Impaired language functions | |
− | + | ## Changes in personality, behavior, or comportment | |
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
− | |||
Line 74: | Line 49: | ||
Alzheimer dementia | Alzheimer dementia | ||
− | + | * presenting cognitive syndrome: amnestic, logopenic variant, posterior cortical atrophy | |
− | + | * risk factors: age, vascular risk factors, TBI, low education, genetics | |
− | + | * characteristic lesions: amyloid plaque (Abeta42), fibrillary tangles (Ptau) | |
− | |||
− | |||
− | |||
Vascular dementia | Vascular dementia | ||
− | + | * presenting cognitive syndrome: large vessel is highly variable; small vessel presents with subcortical cognitive impairment | |
− | + | * risk factors: age, vascular risk factors (HTN, DM, HLD, smoking, etc.), genetics | |
− | + | * characteristic lesions: white matter hyperintensities, microhemorrhages, lacunes, enlarged perivascular spaces | |
− | |||
− | |||
− | |||
Frontotemporal dementia | Frontotemporal dementia | ||
− | + | * presenting cognitive syndrome: language variant - nfPPA (mostly tau), SD (mostly TDP), lvPPA (AD > FTLD); behavioral variant - TDP or tau | |
− | + | * risk factors: environmental factors, genetics | |
− | + | * characteristic lesions: Tau (Pick’s disease, FTDP-17), TDP-43 (various types including ALS-FTLD), FUS | |
− | |||
− | |||
− | |||
Parkinson disease dementia | Parkinson disease dementia | ||
− | + | * presenting cognitive syndrome: subcortical dementia | |
− | + | * risk factors: TBI, family history of PD, environmental pesticides | |
− | + | * characteristic lesions: alpha-synuclein predominantly in subcortical structures | |
− | |||
− | |||
− | |||
Lewy body dementia | Lewy body dementia | ||
− | + | * presenting cognitive syndrome: hallucinations, fluctuation in cognition and level of alertness, Parkinsonism, visuospatial problems | |
− | + | * risk factors: family history of PD, susceptibility genes (APOE4), low education, vascular risk factors, depression and anxiety. Protective: smoking, history of cancer | |
− | + | * characteristic lesions: alpha-synuclein predominantly in cortical area, high degree of coexistence of amyloid pathology | |
− | |||
− | |||
− | |||
Progressive supranuclear palsy | Progressive supranuclear palsy | ||
− | + | * presenting cognitive syndrome: slow vertical saccade, gait instability, Parkinsonism | |
− | + | * risk factors: not well understood | |
− | + | * characteristic lesions: tufted astrocytes, tau and neurodegeneration in brainstem and basal ganglia | |
− | |||
− | |||
− | |||
Corticobasal degeneration | Corticobasal degeneration | ||
+ | * presenting cognitive syndrome: asymmetrical apraxia, asymmetrical dystonia or myoclonus, and Parkinsonism | ||
+ | * risk factors: not well understood | ||
+ | * characteristic lesions: achromatic ballooned neurons, 4R tau mostly, astrocytic plaques, parietal and temporal atrophy | ||
− | |||
− | |||
− | |||
− | |||
− | |||
== References == | == References == |
Revision as of 09:42, 13 June 2021
Mild cognitive impairment definitions
- Alzheimer Disease Research Center (ADRC) criteria (Albert et al, 2011)
- Concern regarding an intraindividual change in cognition
- Impairment in one or more cognitive domains
- Preservation of independence in functional abilities
- Not demented
- Petersen criteria (Petersen 2016)
- Memory complaints per subject and/or collateral source
- Intact activities of daily living
- Clinical dementia rating scale of 0.5
- Performance on a delayed memory test that is at least one standard deviation below the mean for the subject’s age
- Epidemiology (Petersen 2016)
- 15-20% of patients over the age of 60 have MCI
- The annual rate in which MCI progresses to dementia varies between 8% and 15% per year
Levels of Functioning (Salardini 2019)
- Activities of daily living: dressing, bathing, toileting, continence, transferring, eating
- Instrumental activities of daily living: shopping, preparing food, housework, laundry, use transportation, medication compliance, handling finances
- Advanced activities of daily living: vocational skills, vocational knowledge, hobby-related mastery, music, art
Dementia definition (McKhann 2011)
Cognitive or behavioral (neuropsychiatric) symptoms that:
- Interfere with the ability to function at work or at usual activities; and
- Represent a decline from previous levels of functioning and performing; and
- Are not explained by delirium or major psychiatric disorder.
- Cognitive impairment is detected and diagnosed through a combination of
- History-taking from the patient and a knowledgeable informant and
- Objective cognitive assessment, either a “bedside” mental status examination or neuropsychological testing
- The cognitive or behavioral impairment involves a minimum of two of the following domains:
- Impaired ability to acquire and remember new information
- Impaired reasoning and handling of complex tasks, poor judgment
- Impaired visuospatial abilities
- Impaired language functions
- Changes in personality, behavior, or comportment
Epidemiology: 70-80% of dementia is contributable to Alzheimer’s pathology, vascular disease, or some combination of the two; Lewy body disease contributes to 5%; the rest includes a large number of pathologies with lower prevalence (McKhann 2011)
Basic Overview of Dementias (McKhann 2011)
Alzheimer dementia
- presenting cognitive syndrome: amnestic, logopenic variant, posterior cortical atrophy
- risk factors: age, vascular risk factors, TBI, low education, genetics
- characteristic lesions: amyloid plaque (Abeta42), fibrillary tangles (Ptau)
Vascular dementia
- presenting cognitive syndrome: large vessel is highly variable; small vessel presents with subcortical cognitive impairment
- risk factors: age, vascular risk factors (HTN, DM, HLD, smoking, etc.), genetics
- characteristic lesions: white matter hyperintensities, microhemorrhages, lacunes, enlarged perivascular spaces
Frontotemporal dementia
- presenting cognitive syndrome: language variant - nfPPA (mostly tau), SD (mostly TDP), lvPPA (AD > FTLD); behavioral variant - TDP or tau
- risk factors: environmental factors, genetics
- characteristic lesions: Tau (Pick’s disease, FTDP-17), TDP-43 (various types including ALS-FTLD), FUS
Parkinson disease dementia
- presenting cognitive syndrome: subcortical dementia
- risk factors: TBI, family history of PD, environmental pesticides
- characteristic lesions: alpha-synuclein predominantly in subcortical structures
Lewy body dementia
- presenting cognitive syndrome: hallucinations, fluctuation in cognition and level of alertness, Parkinsonism, visuospatial problems
- risk factors: family history of PD, susceptibility genes (APOE4), low education, vascular risk factors, depression and anxiety. Protective: smoking, history of cancer
- characteristic lesions: alpha-synuclein predominantly in cortical area, high degree of coexistence of amyloid pathology
Progressive supranuclear palsy
- presenting cognitive syndrome: slow vertical saccade, gait instability, Parkinsonism
- risk factors: not well understood
- characteristic lesions: tufted astrocytes, tau and neurodegeneration in brainstem and basal ganglia
Corticobasal degeneration
- presenting cognitive syndrome: asymmetrical apraxia, asymmetrical dystonia or myoclonus, and Parkinsonism
- risk factors: not well understood
- characteristic lesions: achromatic ballooned neurons, 4R tau mostly, astrocytic plaques, parietal and temporal atrophy
References
Albert, M. S. et al. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 7, 270–279 (2011) https://pubmed.ncbi.nlm.nih.gov/21514249/
McKhann, G. M. et al. The diagnosis of dementia due to Alzheimer’s disease: Recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 7, 263–269 (2011). https://pubmed.ncbi.nlm.nih.gov/21514250/
Petersen, R. C. Mild Cognitive Impairment. Continuum 22, 404–18 (2016) https://pubmed.ncbi.nlm.nih.gov/27042901/
Salardini, A. An Overview of Primary Dementias as Clinicopathological Entities. Semin. Neurol. 39, 153–166 (2019). https://pubmed.ncbi.nlm.nih.gov/30925609/